The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Lipoproteins in the Central Nervous System
Abstract
A bstract: Although the synthesis and metabolism of plasma lipoproteins are well characterized, little is known about lipid delivery and clearance within the central nervous system (CNS). Our work has focused on characterizing the lipoprotein particles present in the cerebrospinal fluid (CSF) and the nascent particles secreted by astrocytes. In addition to carrying lipids, we have found that β‐amyloid (Ab) associates with lipoproteins, including the discoidal particles secreted by cultured astrocytes and the spherical lipoproteins found in CSF. We believe that association with lipoproteins provides a means of transport and clearance for Aβ. This process may be further influenced by an interaction between Ab and apoprotein E (apoE), the primary protein component of CNS lipoproteins. Specifically, we have investigated the formation and physiologic relevance of a SDS‐stable complex between apoE and Aβ. In biochemical assays, native apoE2 and E3 (associated with lipid particles) form an SDS‐stable complex with Ab that is 20‐fold more abundant than the apoE4:Aβ complex. In cell culture, native apoE3 but not E4 prevents Aβ‐induced neurotoxicity by a mechanism dependent on cell surface apoE receptors. In addition, apoE and the inhibition of apoE receptors prevent Aβ‐induced astrocyte activation. Therefore, we hypothesize that the protection from Aβ‐induced neurotoxicity afforded by apoE3 may result from clearance of the peptide by SDS‐stable apoE3:Aβ complex formation and uptake by apoE receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glia, in particular astrocytes, are the primary cell type in the central nervous system that synthesize apoE, whereas apoJ is expressed by glia and neurons (reviewed in Ref. 2).”
From Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures (2000) · cites this paper as [2]
Citations
Cites
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830
Isoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540
Self-citationSanan, D. A., Weisgraber, K. H., Russell, S. J., Mahley, R. W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B., & Roses, A. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117407 · Cited by 404
Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.
Linton, M. F., Gish, R., Hubl, S. T., Bütler, E., Esquivel, C., Bry, W. I., Boyles, J. K., Wardell, M. R., & Young, S. G. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115288 · Cited by 367
Holtzman, D. M., Bales, K. R., Wu, S., Bhat, P., Parsadanian, M., Fagan, A. M., Chang, L. K., Sun, Y., & Paul, S. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6179 · Cited by 349
Self-citationGhiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N. H., Tomita, M., Wisniewski, T., & Frangione, B. (1993) · Biochemical Journal · doi:10.1042/bj2930027 · Cited by 304
Nascent astrocyte particles differ from lipoproteins in CSF
LaDu, M. J., Gilligan, S. M., Lukens, J. R., Cabana, V. G., Reardon, C. A., Van Eldik, L. J., & Holtzman, D. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052070.x · Cited by 285
Flagged first, then by citations
Research works printed but not linked: 43
- Li W‐H., 1988, The apolipoprotein multigene family: biosynthesis, structure, structure‐function relationships, and evolution, J. Lipid Res., 29, 245, 10.1016/S0022-2275(20)38532-1 · DOI
- 10.1097/00005072-199604000-00012 · DOI · Paper page
- Kim D.H., 1996, Human apoprotein E receptor 2, A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem., 271, 8373
- Silva H.V., 1990, A 70‐kDa apoprotein designated apoJ is a marker for sub‐classes of human plasma high density lipoproteins, J. Biol. Chem., 265, 13240, 10.1016/S0021-9258(19)38290-0 · DOI
- 10.1073/pnas.76.9.4646 · DOI · Paper page
- 10.1016/S0021-9258(18)47945-8 · DOI · Paper page
- 10.1016/0896-6273(93)90070-8 · DOI · Paper page
- 10.1074/jbc.271.14.8373 · DOI · Paper page
- 10.1097/00005072-199604000-00012 · DOI · Paper page
- 10.1074/jbc.270.22.13070 · DOI
- 10.1073/pnas.93.9.4229 · DOI · Paper page
- 10.1006/exnr.1997.6710 · DOI
- 10.1007/BF02591657 · DOI
- Smith K.M., 1990, Cellular localization of apolipoprotein D and lecithin: cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization, J. Lipid Res., 31, 995, 10.1016/S0022-2275(20)42739-7 · DOI
- 10.1016/0166-2236(92)90190-J · DOI
- 10.1016/0166-2236(94)90156-2 · DOI
- 10.1073/pnas.90.5.1977 · DOI · Paper page
- 10.1111/j.1749-6632.1996.tb34431.x · DOI
- 10.1016/S0140-6736(95)91411-0 · DOI
- 10.1016/S0003-4975(97)00757-1 · DOI
- Slooter A.J.C., 1997, Apolipoprotein E epsilon‐4 and the risk of dementia with stroke‐a population based investigation, J. Am. Med. Assoc., 277, 818, 10.1001/jama.1997.03540340052032 · DOI
- 10.1002/ana.410420417 · DOI
- Hammad S.M., 1997, Interaction of apolipoprotein J‐amyloid beta‐peptide complex with low density lipoprotein receptor‐related protein‐2/megalin, A mechanism to prevent pathological accumulation of amyloid beta peptide. J. Biol. Chem., 272, 18644
- 10.1016/0006-8993(91)91092-F · DOI · Paper page
- 10.1007/BF00296787 · DOI · Paper page
- 10.1074/jbc.270.13.7563 · DOI · Paper page
- 10.1074/jbc.270.16.9039 · DOI · Paper page
- 10.1073/pnas.92.3.763 · DOI · Paper page
- 10.1038/ng0996-55 · DOI · Paper page
- 10.1523/JNEUROSCI.18-01-00195.1998 · DOI · Paper page
- 10.1006/bbrc.1996.0940 · DOI
- 10.1002/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H · DOI
- 10.1046/j.1471-4159.1997.68020721.x · DOI · Paper page
- 10.1016/S0021-9258(18)87014-4 · DOI · Paper page
- Innerarity T.L.et al.1986. Type III hyperlipoproteinemia: a focus on lipoprotein receptor‐apolipoprotein E2 interactions. In Advances in Experimental Medicine and Biology. A. Angel & J. Frohlich Eds.: 273–288. Plenum Press. New York. · DOI
- 10.1073/pnas.92.21.9480 · DOI · Paper page
- 10.1074/jbc.270.45.27063 · DOI · Paper page
- 10.1016/0092-8674(95)90320-8 · DOI · Paper page
- 10.1002/ana.410370212 · DOI · Paper page
- 10.1212/WNL.49.1.56 · DOI · Paper page
- 10.1038/1243 · DOI · Paper page
- 10.1046/j.1471-4159.1998.71041626.x · DOI · Paper page
- 10.1073/pnas.95.26.15598 · DOI
Cited by
Sorted by citations
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
Self-citationCharacterization of four lipoprotein classes in human cerebrospinal fluid
Koch, S., Donarski, N., Goetze, K., Kreckel, M., Stuerenburg, H.-J., Buhmann, C., & Beisiegel, U. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31605-9 · Cited by 298
Abildayeva, K., Jansen, P. J., Hirsch-Reinshagen, V., Bloks, V. W., Bakker, A. H. F., Ramaekers, F. C. S., de Vente, J., Groen, A. K., Wellington, Kuipers, F., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601019200 · Cited by 267
HDL and cholesterol handling in the brain
Vitali, C., Wellington, C. L., & Calabresi, L. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu148 · Cited by 254
Microglia in Brain Development, Homeostasis, and Neurodegeneration
Bohlen, C. J., Friedman, B. A., Dejanovic, B., & Sheng, M. (2019) · Annual Review of Genetics · doi:10.1146/annurev-genet-112618-043515 · Cited by 212
Metadata
- Authors
- LADU, M. J., REARDON, C., VAN ELDIK, L., FAGAN, A. M., BU, G., HOLTZMAN, D., & GETZ, G. S.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2000-04
- Volume
- 903
- Issue
- 1
- Pages
- 167-175
- ISSN
- 0077-8923
- 1749-6632
- Cited by
- 167
- References
- 14
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review